other material
confidence high
sentiment neutral
materiality 0.55
Shuttle Pharma amends 8-K, cutting pre-funded warrant count to 9,741,751
Shuttle Pharmaceuticals Holdings, Inc.
- Actual pre-funded warrants issued as of Sept 9, 2026: 9,741,751, not the ~16,932,508 maximum previously disclosed.
- Warrants purchase shares of $0.00001 par common stock; no other terms of the original issuance changed.
- Correction lowers potential warrant-related dilution by roughly 43% versus the earlier 8-K figure.
- Amendment filed Sept 24, 2026; original 8-K filed Sept 15, 2026; no other modifications made.